爱尔康在2025年SECO大会上推出最新的隐形眼镜、干眼症和数字创新产品-动脉网

Alcon Unveils Latest Contact Lens, Dry Eye and Digital Innovations at SECO 2025

爱尔康等信源发布 2025-02-27 08:00



可切换为仅中文







Full commercial availability of PRECISION7 sphere and toric, the latest addition to the Alcon WaterInnovations contact lens portfolio

PRECISION7球面和散光镜片的全面商业上市，这是Alcon WaterInnovations隐形眼镜系列的最新产品。

Alcon dry eye innovations feature new SYSTANE PRO Preservative-Free and AR-15512 (Acoltremon 0.003%) Phase 3 clinical study results

阿尔康干眼症创新产品推出了新的无防腐剂SYSTANE PRO和AR-15512（Acoltremon 0.003%）的第三阶段临床研究结果。

New MARLO features including digital resources and Alcon OTC product availability

新MARLO功能包括数字资源和Alcon OTC产品可用性

FORT WORTH, Texas, February 26, 2025

德克萨斯州沃斯堡，2025年2月26日

– Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today unveiled its robust line-up of announcements and updates for the 2025 SECO International meeting in Atlanta, Georgia. Alcon is highlighting the full commercial availability of PRECISION7

– 全球眼科护理领域的领导者爱尔康（SIX/NYSE: ALC），致力于帮助人们获得清晰视力，今天公布了其在2025年佐治亚州亚特兰大SECO国际会议上的强大公告和更新阵容。爱尔康重点展示了PRECISION7的全面商业可用性。

sphere and toric, as well as debuting its latest advancement in the treatment of dry eye. Additionally, the company is showcasing its expanded patient engagement tools for allergy sufferers with MARLO, including OTC Pataday

球面和散光，以及其在干眼症治疗领域的最新进展。此外，公司还展示了其扩展的患者互动工具，针对过敏患者推出的MARLO，包括非处方药Pataday。

availability.

可用性。

“Alcon’s presence at this year’s SECO International represents our steadfast commitment to bringing the latest innovations and digital resources to address the needs of today’s patients and Eye Care Professionals,” said Kristen Brotherson, General Manager, U.S. Vision Care, Alcon. “We are proud to highlight data from our investigational dry eye product, debut new innovations across contact lenses and ocular health—including updated MARLO features—as we continue to advance treatment options and resources for everyone.”.

“Alcon在今年的SECO国际会议上的亮相代表了我们坚定不移地致力于带来最新的创新和数字资源，以满足当今患者和眼科护理专业人士的需求，” Alcon美国视力保健总经理Kristen Brotherson表示。“我们很自豪能够展示我们研究中的干眼产品数据，推出在隐形眼镜和眼部健康领域的新创新——包括更新的MARLO功能——因为我们持续为所有人推进治疗选择和资源。”

PRECISION7 sphere and toric join Alcon’s WaterInnovations contact lens portfolio, expanding the power of water to more patients

PRECISION7 球面和散光镜片加入爱尔康的 WaterInnovations 隐形眼镜系列，将水的力量带给更多患者。

PRECISION7—the lens that delivers breakthrough performance and an easy-to-remember replacement schedule closer to the daily lenses that eye care professionals prefer

精密7——提供突破性性能的镜片，并且其更换周期更接近眼科护理专业人士偏好的日抛型镜片，易于记忆。

—is now fully commercially available to all eye care professionals in the U.S.

—现在已全面商业上市，美国所有眼科护理专业人士均可使用。

1,2

The lens is the latest addition to the Alcon WaterInnovations™ portfolio, ECPs preferred choice for all day comfort.

该镜片是爱尔康WaterInnovations™系列的最新产品，是ECP们追求全天舒适度的首选。

Made of serafilcon A, a new SiHy material, PRECISION7’s breakthrough ACTIV-FLO

PRECISION7 由新型SiHy材料serafilcon A制成，其突破性的ACTIV-FLO技术

System is a unique combination of a water-loving moisturizing agent embedded in the lens matrix and a proprietary replenishing agent that is continuously released to moisturize the surface over seven days.

系统是一种独特的组合，包含嵌入镜片基质中的亲水保湿剂和专有的补充剂，可持续释放以在七天内滋润表面。

4-6

More information about PRECISION7 will be available at the Alcon booth.

有关PRECISION7的更多信息，请访问爱尔康展位。

Alcon to showcase the latest addition to the SYSTANE portfolio, SYSTANE PRO PF

爱尔康将展示速润滴眼液系列的最新产品——速润PRO PF。

Developed exclusively to offer dry eye symptom relief, SYSTANE

专为缓解干眼症状而开发，SYSTANE

PRO Preservative-Free (PF) is a one-of-a-kind, triple-action formula that provides sustained hydration, restores tear film stability, and protects against further irritation of dry eyes.

PRO无防腐剂（PF）是一种独特的三重作用配方，能够提供持续的水润保湿、恢复泪膜稳定性，并保护干燥的眼睛免受进一步刺激。

7,8

7，8

With active ingredient propylene glycol, hyaluronate supports the eyes’ pH balance, delivering long-lasting dry eye symptom relief for all major types of dry eyes, which affects an estimated 45.5 million patients in the United States.

含有活性成分丙二醇、透明质酸，可维持眼睛的酸碱平衡，为所有主要类型的干眼症提供长效的症状缓解，据估计，美国有 4550 万名干眼症患者。

8-10

New Phase 3 clinical study results presented for AR-15512 (Acoltremon 0.003%), a potential new pharmaceutical treatment option for DED

AR-15512（Acoltremon 0.003%）是一种潜在的干眼病（DED）新药治疗选择，其第三阶段临床研究结果已公布。

11,*

Investigators Selina R. McGee, OD, FAAO, and Cory Lappin, OD, MS, FAAO will present

调查员塞琳娜·R·麦基博士、美国眼科学会会员，以及科里·拉平博士、理学硕士、美国眼科学会会员将进行展示。

Ocular Surface Staining Reductions With Acoltremon 0.003%: Results From Phase 3 Pivotal Clinical Studies (COMET-2 and COMET-3)

使用Acoltremon 0.003%减少眼部表面染色：来自三期关键临床研究（COMET-2和COMET-3）的结果

at a networking breakfast on Thursday, February 27 at the Omni Atlanta Hotel at Centennial Park (190 Marietta St NW, Atlanta, GA 30303) from 6:30 AM-7:45 AM ET.

2月27日星期四，在百年纪念公园奥姆尼亚特兰大酒店（地址：乔治亚州亚特兰大市西北玛丽埃塔街190号，邮编30303）举行的早餐联谊会，时间为东部时间早上6:30至7:45。

Acoltremon 0.003% is Alcon’s pharmaceutical dry eye pipeline candidate and a potent, first-in-class transient receptor potential melastatin 8 (TRPM8) agonist.

Acoltremon 0.003% 是爱尔康公司研发的干眼症药物候选产品，也是一种强效的、首创的瞬时受体电位黑素瘤8（TRPM8）激动剂。

11,*

MARLO latest enhancements center on fostering patient engagement with OTC products availability and added resource for allergy sufferers

MARLO的最新改进集中在促进患者参与，提供非处方药产品的可用性，并为过敏患者增加资源。

At SECO 2025, MARLO - Alcon’s digital solution - is celebrating five years of continuous innovation within the platform. Alcon will showcase MARLO’s expanded digital tools and highlight its latest features, including:

在2025年SECO大会上，MARLO——爱尔康的数字化解决方案——将迎来该平台持续创新的五周年。爱尔康将展示MARLO扩展的数字化工具，并重点介绍其最新功能，包括：

MARLO remains Alcon's one-stop solution for ordering contact lenses, contact lens care products, including OPTI-FREE

MARLO 仍然是 Alcon 用于订购隐形眼镜和隐形眼镜护理产品（包括 OPTI-FREE）的一站式解决方案。

and CLEAR CARE

和CLEAR CARE

, and Alcon OTC products from Pataday and SYSTANE (available with contact lens order). COMING SOON: our latest innovation in dry eye relief, SYSTANE PRO PF.

，以及来自Pataday和SYSTANE的Alcon非处方产品（可随隐形眼镜订单提供）。即将推出：我们在干眼症缓解方面的最新创新产品，SYSTANE PRO PF。

On the MARLO App, patients can now opt in for push notifications alerting them to high local allergen levels.

在 MARLO 应用程序上，患者现在可以选择接收提醒他们当地过敏原水平高的推送通知。

†

This new feature is designed to help more patients understand their exposure to allergens and easily access available OTC solutions on a single platform.

这项新功能旨在帮助更多患者了解他们的过敏原暴露情况，并在一个平台上轻松获取可用的非处方药解决方案。

Alcon unveils new digital Spanish language Pataday resources for allergy sufferers

爱尔康推出新的数字西班牙语Pataday资源，助力过敏患者

As part of these allergy resource enhancements, Alcon is also showcasing new English and Spanish language resources available on Pataday.com to help ECPs better communicate key information about Pataday to their patients with allergies.

作为这些过敏资源改进的一部分，爱尔康还展示了 Pataday.com 上可用的新英文和西班牙文资源，以帮助眼科护理专业人员更好地向过敏患者传达有关 Pataday 的重要信息。

More on each of these announcements, including samples, demonstrations and literature, will be available at Alcon Booth #235 from February 26 – March 2, 2025.

有关这些公告的更多信息，包括样品、演示和文献，将于2025年2月26日至3月2日在Alcon展位#235提供。

About Alcon

关于爱尔康

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors.

爱尔康帮助人们清晰看世界。作为拥有75年以上历史的眼科护理全球领导者，我们提供最广泛的产品组合来增强视力并改善人们的生活。我们的外科和视力保健产品每年惠及140多个国家中超过2.6亿患有白内障、青光眼、视网膜疾病和屈光不正等眼部问题的人群。

Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at .

我们的两万五千多名员工通过创新的产品、与眼科护理专业人士的合作以及提升优质眼科护理可及性的项目，正在改善人们的生活质量。欲了解更多信息，请访问。

www.alcon.com

。

Important Safety Information for Precision7

Precision7的重要安全信息

(serafilcon A) contact lenses:

（serafilcon A）隐形眼镜：

For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur. See product instructions for complete wear, care and safety information.

用于日常佩戴或最长连续6晚佩戴，适用于近视/远视。长时间佩戴会增加严重眼部问题的风险（如角膜溃疡）。在极少数情况下，可能导致视力丧失。可能会出现不适、轻微灼烧感或刺痛等副作用。有关完整的佩戴、护理和安全信息，请参阅产品说明书。

Rx Only..

仅处方药。

*AR-15512 is an investigational drug product that has been filed with the U.S. Food and Drug Administration (FDA) for approval; it is not yet approved.

*AR-15512 是一种已提交美国食品药品监督管理局 (FDA) 审批的在研药物，尚未获得批准。

**Based on agreement with the statement 'I believe daily disposable lenses are better for my patients overall.”

**基于对“我相信日抛型镜片总体上更适合我的患者”这一陈述的认同。**

†Push notifications are for iOS only. Android coming soon.

†推送通知仅适用于iOS。Android即将推出。

References

参考文献

In a 2-week prospective clinical study in the US; n=181; CLEAR CARE

在美国进行的一项为期2周的前瞻性临床研究；n=181；CLEAR CARE

Cleaning & Disinfecting Solution used for cleaning and disinfection; Alcon data on file, 2023.

用于清洁和消毒的清洁和消毒溶液；Alcon 数据存档，2023。

Based on a survey of 500 US optometrists who fit contact lenses; Alcon data on file, 2023.

基于对500名美国验光师的调查，这些验光师负责适配隐形眼镜；爱尔康公司2023年存档数据。

Alcon Data on File, 2025.

爱尔康数据存档，2025。

Zheng Y, Dou J, Wang Y, et al. Sustained release of a polymeric wetting agent from a silicone-hydrogel contact lens material. ACS Omega. 2022;7(33):29223-29230. doi: 10.1021/acsomega.2c03310.

郑毅、窦健、王莹等。硅水凝胶隐形眼镜材料中聚合物润湿剂的持续释放。《ACS Omega》。2022；7（33）：29223-29230。doi: 10.1021/acsomega.2c03310。

Phan CM, Chan VWY, Drolle E, et al. Evaluating the in vitro wettability and coefficient of friction of a novel and contemporary reusable silicone hydrogel contact lens materials using an in vitro blink model. Cont Lens Anterior Eye. 2024; Volume 47(2):1-11.

Phan CM, Chan VWY, Drolle E, 等。使用体外眨眼模型评估一种新型和现代可重复使用的硅水凝胶隐形眼镜材料的体外润湿性和摩擦系数。《隐形眼镜与前眼》。2024年；第47卷第2期：1-11页。

PRECISION7

Instructions for Use.

使用说明。

Systane

思然

PRO PF Label.

专业版PF标签。

Alcon data on file, 2025.

爱尔康数据存档，2025。

Alcon data on file, 2024.

爱尔康数据存档，2024。

Dry Eye Products Markets Report, Market Scope, 2023.

干眼产品市场报告，市场范围，2023年。

McGee S, Evans D, et al. Ocular Surface Staining Reductions with Acoltremon 0.003%: Results From Phase 3 Pivotal Clinical Studies (COMET-2 and COMET-3) SECO International. Atlanta. 2025.

麦基 S，埃文斯 D 等。使用 0.003% Acoltremon 减少眼部表面染色：来自 III 期关键临床研究（COMET-2 和 COMET-3）的结果，SECO 国际会议，亚特兰大，2025。

Connect with us on

与我们联系

Facebook

脸书

and

和

领英

Investor Relations

投资者关系

Allen Trang

艾伦·特朗